Great Basin Scientific Inc - 500 Beiträge pro Seite

[Billinger]

Great Basin Scientific Inc GBSN

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies.
The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases.
The Great Basin molecular diagnostics system is uniquely capable of answering both the ‘What is it?’ question—answered by a low-cost, low-plex assay—and the
‘What is causing it?’ question, identified by a multi-plex panel. The Company has FDA Clearance on tests for Clostridium difficile and Group B streptococcus.
Low-plex tests in development include SA Nasal and Staph ID/R and multi-plex panels being developed include Fungal Pathogens, Shiga toxin-producing E. coli (STEC) and
Food-borne Pathogens (GI Panel). The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every
serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. Fast, accurate results. More answers. One easy-to-use and cost-effective system.
Only Great Basin is delivering a powerful product pipeline of tests and panels that allows every lab to adopt molecular diagnostics that will assist clinicians in better
diagnosing and managing patients outcomes. The company sells its diagnostic tests through a direct sales force in the United States, as well as through
distributors in the European Union and New Zealand. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah.


Auf stocktwits und twitter ist ein ziemliches Diskussionsbedarf zu dieser Aktie entbrannt, umso mehr verwundert es mich, dass es hier noch keinen eigenen Thread zu GBSN gibt.

Aktuell warten alle auf 2 FDA-Genehmigungen, die den Kurs der Aktie nach oben pushen sollte.
Auf der anderen Seite ist ein Reverse-Split auf dem Tisch

[Billinger]

http://finance.yahoo.com/news/great-basin-announces-reverse-…

Okay, heute findet ein 60:1 Split statt. Ab Montag gibt es nur noch einen 3.2 mil float, der aber durch Warrants wieder erhöht werden wird auf ca. 10 Mil..

Great Basin Scientific, Inc. (GBSN), a molecular diagnostics company, announced today that a 1-for-60 reverse split of its common stock will be effective at 5:00 pm EST on December 11, 2015. The Company’s common stock will open for trading on the Nasdaq Capital Market on Monday, December 14, 2015 on a post-split basis. At the effective time of the reverse stock split, every 60 shares of the Company’s issued and outstanding common stock, par value $0.001, will be consolidated into 1 newly issued and outstanding share of common stock, par value of $0.0001.

The reverse stock split will reduce the number of shares of the Company’s outstanding common stock from approximately 190.7 million to approximately 3.2 million. Proportional adjustments will be made to the Company's outstanding preferred shares, unit purchase options, stock options, warrants, and equity incentive plan. The number of authorized shares of the Company's common stock will remain unchanged.

Effectiveness of the reverse stock split will also cure the Company’s previously announced Authorized Share Failure and at that time the Series C Warrants will become exercisable for the next 25 trading days as previously announced on December 7, 2015.

Stockholders who have existing stock certificates will receive written instructions by mail from the Company's transfer agent, American Stock Transfer & Trust Company, LLC. Stockholders who hold their shares in brokerage accounts or "street name" are not required to take any action to effect the exchange of their shares. Such stockholders will be contacted by their brokers with instructions. To the extent the reverse stock split would result in a stockholder owing a fractional share, such stockholder will have the number of post-reverse split shares to which they are entitled rounded up to the next whole number of shares. No stockholders will receive cash in lieu of fractional shares.

Additional information regarding the Company's reverse stock split is available in the definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission (SEC) on November 3, 2015.